Evidence map›Paper›PMID 36097290›Full record

ArticleNature structural & molecular biology2022

Cryo-EM structure of disease-related prion fibrils provides insights into seeding barriers.

Qiuye Li, Christopher P Jaroniec, Witold K Surewicz

Open access · greenAbstract read
In one paragraph

Article in Nature structural & molecular biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 22 citations in OpenAlex.

  1. PrPStem cell reports · 2026
    Article
  2. Review
  3. Review
  4. The Glycine-Rich Region as a Flexible Molecular Glue Promoting hPrPJournal of chemical information and modeling · 2025
    Article
  5. Review
  6. Mechanisms and pathology of protein misfolding and aggregation.Nature reviews. Molecular cell biology · 2023
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Structural biology of ex vivo mammalian prions.The Journal of biological chemistry · 2022
    Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Qiuye LiDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA.ORCID 0000-0001-7869-8814
Christopher P JaroniecDepartment of Chemistry and Biochemistry, The Ohio State University, Columbus, OH, USA.ORCID 0000-0003-0364-2888
Witold K SurewiczDepartment of Physiology and Biophysics, Case Western Reserve University, Cleveland, OH, USA. wks3@case.edu.ORCID 0000-0001-7940-6027
Case Western Reserve University · USThe Ohio State University · US

Funding

Molecular Mechanisms of Prion and Amyloid PropagationR01GM094357 · NIGMS · OHIO STATE UNIVERSITY · PI JARONIEC, CHRISTOPHER P · 2011 to 2022
$3.2M
Replication mechanism of human prionsR01NS103848 · NINDS · CASE WESTERN RESERVE UNIVERSITY · PI SAFAR, JIRI G., SUREWICZ, WITOLD K · 2018 to 2022
$2.6M
NIGMS NIH HHS R01 GM094357NINDS NIH HHS R01 NS103848
6 · The paper itself

Abstract

One of the least understood aspects of prion diseases is the structure of infectious prion protein aggregates. Here we report a high-resolution cryo-EM structure of amyloid fibrils formed by human prion protein with the Y145Stop mutation that is associated with a familial prion disease. This structural insight allows us not only to explain previous biochemical findings, but also provides direct support for the conformational adaptability model of prion transmissibility barriers.

Indexed as

Prion DiseasesPrionsAmyloidCryoelectron MicroscopyHumansPrion ProteinsProtein AggregatesAmyloidPrion ProteinsPrionsProtein Aggregates

Identifiers

PMID36097290
PMCPMC9639217
OpenAlexW4295498578

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.